CN1949977B - 抗冠状病毒化合物 - Google Patents

抗冠状病毒化合物 Download PDF

Info

Publication number
CN1949977B
CN1949977B CN2005800143095A CN200580014309A CN1949977B CN 1949977 B CN1949977 B CN 1949977B CN 2005800143095 A CN2005800143095 A CN 2005800143095A CN 200580014309 A CN200580014309 A CN 200580014309A CN 1949977 B CN1949977 B CN 1949977B
Authority
CN
China
Prior art keywords
alkyl
compound
aryl
independently respectively
heterocyclylalkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN2005800143095A
Other languages
English (en)
Chinese (zh)
Other versions
CN1949977A (zh
Inventor
翁启惠
吴宗益
詹家琮
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CN1949977A publication Critical patent/CN1949977A/zh
Application granted granted Critical
Publication of CN1949977B publication Critical patent/CN1949977B/zh
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/325—Carbamic acids; Thiocarbamic acids; Anhydrides or salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pulmonology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Furan Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Pyrane Compounds (AREA)
CN2005800143095A 2004-05-04 2005-05-03 抗冠状病毒化合物 Expired - Fee Related CN1949977B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US56808004P 2004-05-04 2004-05-04
US60/568,080 2004-05-04
PCT/US2005/015227 WO2006073456A2 (en) 2004-05-04 2005-05-03 Anti-coronavirus compounds

Publications (2)

Publication Number Publication Date
CN1949977A CN1949977A (zh) 2007-04-18
CN1949977B true CN1949977B (zh) 2010-09-29

Family

ID=36647910

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2005800143095A Expired - Fee Related CN1949977B (zh) 2004-05-04 2005-05-03 抗冠状病毒化合物

Country Status (7)

Country Link
US (1) US8481571B2 (https=)
JP (1) JP2007536240A (https=)
CN (1) CN1949977B (https=)
AU (1) AU2005323435A1 (https=)
NZ (1) NZ550945A (https=)
TW (1) TWI372048B (https=)
WO (1) WO2006073456A2 (https=)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT2782922T (pt) * 2011-11-25 2018-02-05 The Kitasato Inst Derivados antibacterianos de tilosina e processos para a sua preparação
IN2014MN02539A (https=) * 2012-06-06 2015-07-24 Unither Virology Llc
WO2017059118A1 (en) * 2015-09-29 2017-04-06 Duke University Compositions and methods for identifying and treating dystonia disorders
WO2017201052A1 (en) * 2016-05-16 2017-11-23 Emergent Virology Llc Methods of treating zika virus infection
CN107595906B (zh) * 2017-11-10 2020-10-30 中国药科大学 常春藤皂苷元及其糖苷在制备抗病毒的药物中的应用
EA202193251A1 (ru) 2019-06-05 2022-03-10 Эмори Юниверсити Пептидомиметики для лечения коронавирусной и пикорнавирусной инфекций
CN115698035A (zh) * 2020-04-10 2023-02-03 共晶制药公司 诺如病毒及冠状病毒复制的抑制剂
US12083099B2 (en) 2020-10-28 2024-09-10 Accencio LLC Methods of treating symptoms of coronavirus infection with viral protease inhibitors

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5142056A (en) 1989-05-23 1992-08-25 Abbott Laboratories Retroviral protease inhibiting compounds
JPH0778021B2 (ja) * 1988-04-13 1995-08-23 太陽化学株式会社 下痢症ウイルス感染阻害剤
US5156973A (en) 1988-11-23 1992-10-20 Edward Shanbrom Antiviral blood sampling process and apparatus
HUT64738A (en) 1990-06-01 1994-02-28 Du Pont Merck Pharma Process for preparing 1,4-diamino-2,3-dihydroxi-butane compounds and pharmaceutical compositions contianing them
JPH04297475A (ja) * 1991-03-26 1992-10-21 Yamanouchi Pharmaceut Co Ltd 抗ウイルス剤
US6803466B1 (en) 1997-12-08 2004-10-12 The Scripps Research Institute HIV/FIV protease inhibitors having a small P3 residue

Also Published As

Publication number Publication date
TW200600084A (en) 2006-01-01
US8481571B2 (en) 2013-07-09
NZ550945A (en) 2010-04-30
JP2007536240A (ja) 2007-12-13
TWI372048B (en) 2012-09-11
AU2005323435A1 (en) 2006-07-13
US20060160866A1 (en) 2006-07-20
CN1949977A (zh) 2007-04-18
WO2006073456A2 (en) 2006-07-13
WO2006073456A3 (en) 2006-09-14

Similar Documents

Publication Publication Date Title
US20230148179A1 (en) SMALL MOLECULE INHIBITORS OF SARS-CoV-2 VIRAL REPLICATION AND USES THEREOF
JP3192070B2 (ja) アスパラギン酸プロテアーゼ基質同配体の抗ウイルス性エーテル
ES2395101T3 (es) Medicamentos antivirales para tratamiento de infecciones por arenavirus
PT91828A (pt) Processo para a preparacao de peptideos inibidores de proteases do hiv, uteis para o tratamento da sida
CN1949977B (zh) 抗冠状病毒化合物
JP2024161441A (ja) 呼吸器疾患の処理のための新規な化合物
US20240002332A1 (en) Small Molecule Inhibitors of SARS-CoV-2 Infections
JP2006527185A (ja) 重症急性呼吸器症候群（ｓａｒｓ）の治療または予防するためのグリチルリチンまたはその誘導体
JP2001511124A (ja) エイズ治療薬としての、プロテアーゼ阻害剤およびリバーストランスクリプターゼ阻害剤との３剤組み合わせ物におけるキノキサリン
CN117836272A (zh) 用于治疗或预防冠状病毒感染的3cl蛋白酶小分子抑制剂及其用途
US10683316B2 (en) Synthetic catalase/superoxide dismutase mimetics and methods for treating viral infections
US20250011292A1 (en) Novel rhodanine derivatives and uses thereof
CN113444075A (zh) 二氢吲哚衍生物、及其制法和药物组合物与用途
CN113845484B (zh) 喹唑啉类小分子抑制剂及其在抗肿瘤药物中的应用
CN111320662B (zh) 一类n-苄基取代的二脒那秦衍生物及其药物用途
DK2826371T3 (en) Methods and compositions for inhibiting integrins using tellurium-containing compounds
US12582619B2 (en) Compounds, compositions, and methods for treating or ameliorating, or preventing viral infections
US20240245717A1 (en) Antiviral compounds, compositions, and uses thereof
JP2013538804A (ja) 抗真菌剤およびその使用
CN116554137A (zh) 一种环烷氨基烷氧基取代的芳基并吡喃酮类化合物及其用途
HK40086507B (zh) 用於治疗rna病毒(特别是covid-19)感染的抗病毒化合物及方法
AU2024285970A1 (en) Solid forms of n-(methoxycarbonyl)-3-methyl-l-valyl-(4r)- n-{(1s)-1-cyano-2-[(3s)-2-oxopyrrolidin-3-yl]ethyl}-4-(trifluoromethyl)-l-prolinamide and solvates thereof
CN118416235A (zh) 用于治疗或预防冠状病毒感染的药物组合物及其用途
HK40086507A (zh) 用於治疗rna病毒(特别是covid-19)感染的抗病毒化合物及方法
WO2025038464A1 (en) Sars-cov-2 plpro inhibitors and methods of use thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20100929

Termination date: 20190503

CF01 Termination of patent right due to non-payment of annual fee